糖尿病人过冬,谨记这9点!

2017-01-17 山东省济南医院糖尿病诊疗中心主任 王建华 医学界内分泌频道

mportant; word-wrap: break-word !important;">保持心态平和据调查,大约50%糖尿病患者存在各种各样的心理问题,许多病人容易出现情绪波动,这种情况在冬季尤为突出。而情绪激动除了能引起交感神经兴奋、血压升高之外,还可促进肝糖原分解,使血糖升高,导致病情加重或降低治疗效果。所以,糖尿病患者要学会控制情绪,尽量减少情绪波动。, 冬天,糖尿病病人抵抗力差,更易发生

冬天,糖尿病病人抵抗力差,更易发生感冒而诱发肺部感染;另外,寒冷会刺激交感神经兴奋,使体内儿茶酚胺类神经递质分泌增加,容易导致血糖及血压升高,诱发心脑卒中;除此之外,严寒还会使外周血管收缩,增加糖尿病足的风险。因此,糖尿病患者在冬季需要做好保健,重点做好以下几点:

一 注意控制饮食

为了抵御冬季寒冷,往往需要靠多吃来增加热量的摄入,而冬季人们户外运动偏少,能量消耗不足,再加上寒冷的天气可使交感神经兴奋,肾上腺素等升糖激素分泌增多,这些因素加在一起使得患者冬季血糖往往较其他季节偏高。因此,在冬季,糖尿病患者要注意控制饮食,少吃多餐,适当运动,如果这样仍难控制血糖,可以在医生的指导下,适当调整降糖药剂量。

二 防止受凉感冒

冬季是呼吸道感染的高发季节,而呼吸道感染也是导致糖尿病酮症酸中毒的常见诱因。为了避免受凉感冒,糖尿病人要做好以下几点:

1、居室经常通风,但室温不宜过低;

2、平时加强锻炼,增强体质;

3、天冷出门前戴好口罩、帽子。

三 取暖须防烫伤

冬天为了御寒,许多病人用暖水袋、暖手宝取暖,但由于糖尿病患者多伴有神经病变,对温度不敏感,很容易发生烫伤,严重者可导致足坏疽,因此,尽量避免采用这类方法取暖。此外,还有些老年病人习惯每天用热水泡脚,为避免烫伤,泡前一定要先用手试水温,最好用手腕去试。水温不要超过40摄氏度,泡脚时间不要超过30分钟。泡完要用干毛巾把脚擦干,特别是脚趾缝。

四 加强足部护脚

病程较长的糖尿病人往往合并下肢血管及神经病变,造成脚的末梢循环障碍和感觉迟钝,即使足部受伤也不察觉不到,很容易发展为足坏疽。因此,糖尿病人应特别注意足部保护,穿吸汗、透气性好的棉袜,鞋子要宽松合脚,避免足部外伤及感染。

五 谨防皮肤干燥

冬季天干物燥,常出现皮肤瘙痒,糖尿病人因此引发神经性皮炎甚至湿疹的不鲜见。因此,糖尿病人冬季一定要预防皮肤干燥,特别是小腿及双足,以免破口、皲裂;洗澡、洗脚后须涂抹护肤乳。


六 天冷莫忘喝水

天气寒冷,小便较频。但很多老年人由于口渴中枢不敏感,口渴症状不明显,常常忽视补充水分,导致血粘度升高。一般说来,糖尿病人每天的饮水量不宜低于1500毫升,这样做可以稀释血液,预防心脑血管意外。建议糖尿病人每天早上一起床就要喝杯水,白天多喝,晚饭后少喝,但夜间起夜后要补喝。

七 不宜清晨空腹运动

运动不仅有助于降低血糖、控制体重,也能够增强耐寒能力及机体免疫力。因此,如果没有禁忌证,患者尽量根据自身年龄及身体状况,坚持参加运动(如步行、慢跑、太极拳)。但不提倡晨练,原因有三:

一是早晨气温很低,导致人体产生应激反应,使得血糖升高;

二是清晨空腹锻炼,有低血糖风险;

三是寒冷会使血管骤然收缩,易诱发脑卒中。


因此,户外运动时间最好选在早、晚饭后进行。另外,空气污浊的雾霾天不宜室外活动,可选择在室内运动(散步或做操)。

八 气温骤变勤测血糖

冬日气温时常变动很大,动辄大风降温10摄氏度以上。对于广大糖尿病人来说,这种变化很可能带来血糖波动。因此,当遇到气温骤变或生活方式调整(如增加运动量、减少饭量等)时,要密切监测血糖,以掌握病情变化。

九 保持心态平和

据调查,大约50%糖尿病患者存在各种各样的心理问题,许多病人容易出现情绪波动,这种情况在冬季尤为突出。而情绪激动除了能引起交感神经兴奋、血压升高之外,还可促进肝糖原分解,使血糖升高,导致病情加重或降低治疗效果。所以,糖尿病患者要学会控制情绪,尽量减少情绪波动。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=172099, encodeId=f1a11e20991e, content=谨记了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Mon Jan 23 09:03:34 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171840, encodeId=30be1e18409a, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jan 21 18:29:26 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171094, encodeId=2da21e109456, content=切记不要, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Wed Jan 18 12:40:03 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171086, encodeId=f5b51e108630, content=学到很多呦,我要发盆友圈, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0661967273, createdName=1e14faebm51(暂无匿称), createdTime=Wed Jan 18 11:45:50 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171074, encodeId=32eb1e10744a, content=谢谢!学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d05f2011449, createdName=1e1ef25am85(暂无匿称), createdTime=Wed Jan 18 10:10:32 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-01-23 卡圣

    谨记了,谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=172099, encodeId=f1a11e20991e, content=谨记了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Mon Jan 23 09:03:34 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171840, encodeId=30be1e18409a, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jan 21 18:29:26 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171094, encodeId=2da21e109456, content=切记不要, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Wed Jan 18 12:40:03 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171086, encodeId=f5b51e108630, content=学到很多呦,我要发盆友圈, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0661967273, createdName=1e14faebm51(暂无匿称), createdTime=Wed Jan 18 11:45:50 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171074, encodeId=32eb1e10744a, content=谢谢!学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d05f2011449, createdName=1e1ef25am85(暂无匿称), createdTime=Wed Jan 18 10:10:32 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-01-21 往日如昨

    继续学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=172099, encodeId=f1a11e20991e, content=谨记了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Mon Jan 23 09:03:34 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171840, encodeId=30be1e18409a, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jan 21 18:29:26 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171094, encodeId=2da21e109456, content=切记不要, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Wed Jan 18 12:40:03 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171086, encodeId=f5b51e108630, content=学到很多呦,我要发盆友圈, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0661967273, createdName=1e14faebm51(暂无匿称), createdTime=Wed Jan 18 11:45:50 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171074, encodeId=32eb1e10744a, content=谢谢!学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d05f2011449, createdName=1e1ef25am85(暂无匿称), createdTime=Wed Jan 18 10:10:32 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-01-18 yafeiliutjh

    切记不要

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=172099, encodeId=f1a11e20991e, content=谨记了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Mon Jan 23 09:03:34 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171840, encodeId=30be1e18409a, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jan 21 18:29:26 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171094, encodeId=2da21e109456, content=切记不要, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Wed Jan 18 12:40:03 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171086, encodeId=f5b51e108630, content=学到很多呦,我要发盆友圈, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0661967273, createdName=1e14faebm51(暂无匿称), createdTime=Wed Jan 18 11:45:50 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171074, encodeId=32eb1e10744a, content=谢谢!学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d05f2011449, createdName=1e1ef25am85(暂无匿称), createdTime=Wed Jan 18 10:10:32 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-01-18 1e14faebm51(暂无匿称)

    学到很多呦,我要发盆友圈

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=172099, encodeId=f1a11e20991e, content=谨记了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOWcPEsEP4FrvDcicue5V6rMkmXmY73KjYP59vQrEdjU89iaN4ZkOhsItlHkmGTjhV3b5S3zOQA4E0/0, createdBy=cc261682151, createdName=卡圣, createdTime=Mon Jan 23 09:03:34 CST 2017, time=2017-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171840, encodeId=30be1e18409a, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0a61971598, createdName=往日如昨, createdTime=Sat Jan 21 18:29:26 CST 2017, time=2017-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171094, encodeId=2da21e109456, content=切记不要, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62d381629, createdName=yafeiliutjh, createdTime=Wed Jan 18 12:40:03 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171086, encodeId=f5b51e108630, content=学到很多呦,我要发盆友圈, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0661967273, createdName=1e14faebm51(暂无匿称), createdTime=Wed Jan 18 11:45:50 CST 2017, time=2017-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=171074, encodeId=32eb1e10744a, content=谢谢!学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d05f2011449, createdName=1e1ef25am85(暂无匿称), createdTime=Wed Jan 18 10:10:32 CST 2017, time=2017-01-18, status=1, ipAttribution=)]
    2017-01-18 1e1ef25am85(暂无匿称)

    谢谢!学习!

    0

相关资讯

引起尿糖升高,不只有糖尿病 !

糖尿病患者可以有尿糖阳性,但是尿糖阳性不一定都是糖尿病。正常人尿内有微量葡萄糖,当血糖尝试超过8.96~10.08mmol/L时,肾小管重吸收糖的能力达极限,血糖再高时已超出肾小管上皮细胞重吸收糖的能力(肾糖阈),尿中糖量增多,致使尿糖定性试验阳性。 部分老年人及糖尿病患者血糖超过10.08mmol/L甚至血糖超过13.00-16.80mmol/L可以没有糖尿,这是因为肾糖阈升高所致。&

Diabetes Care:循环中的代谢产物与糖尿病终末期肾病风险之间有何关系?

患者循环中某种修饰的代谢产物的水平能够更快的经历肾功能下降,并导致终末期肾病。这些候选代谢物是否作为危险因素或仅仅是1型糖尿病患者终末期肾病进展的预后生物标志物仍需要进一步研究确定。

JACC:多支血管病变的糖尿病患者CABG后,双重抗血小板治疗是否有必要?

临床实践指南推荐急性冠状动脉综合征(ACS)患者在接受冠状动脉旁路移植术(CABG)后进行双重抗血小板治疗(DAPT)。该研究评估了糖尿病患者在CABG后DAPT的利用率和相关结局。在FREEDOM(未来糖尿病患者:多支血管病变的最佳管理)试验的一项事后非随机分析中,研究人员比较了术后30天接受DAPT(阿司匹林加噻吩并吡啶)和阿司匹林单药治疗的患者结果。主要结果是风险调整的5年FREEDOM全因

STM:糖尿病患者骨折后愈合能力差的机制被破译

根据斯坦福大学医学院的一项最新研究,一种刺激骨干细胞活性的蛋白能够让发生骨折的糖尿病小鼠恢复得更好。研究人员在糖尿病小鼠模型和糖尿病患者的骨组织样本中观察到骨干细胞活性的下降,而这种蛋白能够抵消干细胞活性的下降。他们希望这一发现能够促进开发新方法帮助糖尿病患者从骨折中更好的恢复。相关研究结果发表在国际学术期刊Science Translational Medicine上。全世界有几亿人受到

柳叶刀子刊:中国糖尿病研究进展

日前,《柳叶刀·糖尿病与内分泌学》杂志发表了一篇近年来中国糖尿病研究概况的论述。文章从当前中国研究重点及以后研究方向作了相关陈述。以下为详细内容:近几十年糖尿病患病率急剧增加,中国已成为糖尿病患病人数最多的国家。由于疾病负担的加重,我国开展的糖尿病研究不断增加,不仅包括基础研究还包括临床观点。研究领域也在逐渐多元化,2000年大部分研究集中于疾病临床表现,包括代谢、一般医疗问题及心脏疾病。但201

JAHA:接受非心脏手术的糖尿病患者到底该怎样服用β受体阻滞剂?

术前30天以上服用心脏保护性β受体阻滞剂才能减少死亡率风险,而短期服用β受体阻滞剂与糖尿病患者死亡率的差异无关。